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ABSTRACT We purified and characterized ryanotoxin, an -11.4-kDa peptide from the venom of the scorpion Buthotus
judiacus that induces changes in ryanodine receptors of rabbit skeletal muscle sarcoplasmic reticulum analogous to those
induced by the alkaloid ryanodine. Ryanotoxin stimulated Ca2" release from sarcoplasmic reticulum vesicles and induced a
state of reduced unit conductance with a mean duration longer than that of unmodified ryanodine receptor channels. With
Cs+ as the current carrier, the slope conductance of the state induced by 1 ,tM ryanotoxin was 163 12 pS, that of the state
induced by 1 ,uM ryanodine was 173 ± 26 pS, and that of control channels was 2.3-fold larger (396 25 pS). The distribution
of substate events induced by 1 ,tM RyTx was biexponential and was fitted with time constants -10 times shorter than those
fitted to the distribution of substates induced by 1 ,uM ryanodine. Bath-applied 5 ,tM ryanotoxin had no effect on the
excitability of mouse myotubes in culture. When 5 ,tM ryanotoxin was dialyzed into the cell through the patch pipette in the
whole-cell configuration, there was a voltage-dependent increase in the amplitude of intracellular Ca2+ transients elicited by
depolarizing potentials in the range of -30 to +50 mV. Ryanotoxin increased the binding affinity of [3H]ryanodine in a
reversible manner with a 50% effective dose (ED50) of 0.16 ,uM without altering the maximum number (Bmej of [3H]ryanodine-
binding sites. This result suggested that binding sites for ryanotoxin and ryanodine were different. Ryanotoxin should prove
useful in identifying domains coupling the ryanodine receptor to the voltage sensor, or domains affecting the gating and
conductance of the ryanodine receptor channel.
INTRODUCTION
The ryanodine receptor forms a Ca2+ channel in the sarco-
plasmic reticulum membrane of muscle cells and plays a
key role in excitation-contraction coupling (Coronado et al.,
1994; Meissner, 1994; Ogawa, 1994). In the latter process,
a depolarization of the muscle cell surface membrane leads
to the opening of ryanodine receptors and to the release of
Ca2+ stored in the sarcoplasmic reticulum. This is followed
by the mechanical shortening of the cell. The actual opening
of the ryanodine receptor may occur by a voltage-dependent
charge movement (Ebashi, 1991; Rios and Pizarro, 1991;
McPherson and Campbell, 1993) or by Ca2+ entry into the
cell (Stem and Lakatta, 1992; Wier et al., 1994), and both
mechanisms are mediated by dihydropyridine receptors. A
voltage-dependent mechanism is more prominent in adult
skeletal muscle, whereas a mechanism dependent on Ca2+
entry is more prominent in adult cardiac muscle. On the
other hand, a mixed form of ryanodine receptor activation
by voltage and Ca2+ has been reported in embryonic muscle
(Cognard et al., 1992). Studies of excitation-contraction
coupling in dysgenic myotubes expressing chimeras of skel-
etal and cardiac cDNAs showed that the putative II-III
cytoplasmic loop of the dihydropyridine receptor al subunit
was important for conferring a voltage or a Ca2+-dependent
Ca2+ release mechanism (Tanabe et al., 1990). Whether the
cytoplasmic loop of the a, subunit interacts directly with
Receivedfor publication 23 October 1995 and in finalform 22 April 1996.
Address reprint requests to Dr. Roberto Coronado, Department of Physiology,
University of Wisconsin, 1300 University Ave., Madison, WI 53706. Tel.:
608-263-7487; Fax: 608-265-5512; E-mail: blmlab@vms2.macc.wisc.edu.
C) 1996 by the Biophysical Society
0006-3495/96/08nO7/15 $2.00
the ryanodine receptor or its action is mediated by other
junctional proteins is unknown.
The identification of functional domains on the ryanodine
receptor is essential for understanding how voltage, Ca2 ,
and perhaps other signals bring about the opening of the
pore. However, the large size of the ryanodine receptor
complex (-2000 kDa) has made this task slow and difficult.
A Ca2+-binding domain was identified between amino acid
residues 4489 and 4499 of the skeletal ryanodine receptor.
The functional significance of this domain was suggested by
experiments in which a polyclonal antibody against the
Ca2+-binding sequence increased the ligand sensitivity of
ryanodine receptor channels (Chen et al., 1993). A high-
affinity binding site for the alkaloid ryanodine was located
on a 76-kDa carboxy-terminal fragment most likely be-
tween Arg-4475 and the carboxy-terminal end (Witcher et
al., 1994; Callaway et al., 1994). Based on the drastic
modifications produced by the alkaloid, this domain may be
critically involved in controlling the channel kinetics and
the conductance of the pore. Numerous peptide-binding
domains also seem to be present, as demonstrated by the
tight and specific interactions of ryanodine receptors with
FK506 binding protein (Jayaraman et al., 1992), small and
large peptides from venoms (Morrissette et al., 1995; H.
Valdivia et al., 1992), and al II-III loop peptides (Lu et al.,
1994; El-Hayek et al., 1995). Identification of peptide-
binding domains controlling the gating of ryanodine recep-
tors may prove critical in determining the structural basis of
skeletal-type excitation-contraction coupling, because a me-
chanical interaction of the dihydropyridine receptor and the
skeletal type ryanodine receptor has been proposed to me-
diate Ca2+ release in this tissue (Rios et al., 1991).
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Scorpion neurotoxins are generally small basic peptides,
typically consisting of 60 to 70 amino acid residues that
affect excitable membranes by specifically binding to ion
channels (Adams and Swanson, 1994). Previous studies on
the venom of the scorpion Buthotus judaicus indicated the
presence of two Na+ channel toxins (Lester et al., 1982). In
current clamp experiments with an insect nerve preparation,
B. judaicus insect toxin I (BJ IT-1) induced slight depolar-
ization accompanied by spontaneous or repetitive firing of
action potentials of normal amplitude and shape. On the
other hand, B. judaicus toxin II (BJ IT-I1) induced a gradual
depolarization accompanied by a decrease in the amplitude
of the action potential. Under voltage clamp, IT-I caused an
increase in the Na+ current, whereas IT-II decreased the
Na+ current (Lester et al., 1982).
Here we report the purification of a peptide from the
venom of the scorpion B. judaicus that stimulated ryanodine
receptor channels in cell-free recordings obtained by fusion
of sarcoplasmic reticulum to planar bilayers. In addition, the
peptide stimulated intracellular Ca2+ transients induced by
the depolarization of skeletal muscle myotubes in culture.
This novel peptide was named ryanotoxin or RyTx, based
on the observation that the peptide activated ryanodine
receptors by inducing a long-lived subconductance state that
was functionally similar to the subconductance state in-
duced by ryanodine. Part of this work appeared in abstract
form (Morrissette and Coronado, 1994).
MATERIALS AND METHODS
Preparation of sarcoplamic reticulum
Junctional sarcoplasmic reticulum sedimenting between 35% and 45%
sucrose (w/v) was prepared from rabbit back and thigh muscle as described
elsewhere (Sukhareva et al., 1994). Membranes were stored in liquid
nitrogen in 0.3 M sucrose, 0.1 M KCI, 5 mM Na-piperazine-N,N'-bis-2-
ethanesulfonic acid (Na-PIPES), pH 6.8.
Purification of ryanotoxin
Two separate batches of -500 mg of lyophilized B. judaicus venom were
purchased from Alamone Laboratories (Jerusalem, Israel) and were stored
under vacuum at - 20°C for up to a year without a significant loss of
activity. A total of 10 preparations of purified RyTx were made from these
two batches of venom. Each preparation of RyTx was started from a
separate venom stock solution prepared from --100 mg of lyophilized
venom at a time. The venom powder was resuspended in 3 ml of water
followed by sonication in a bath-type sonicator for 10 min. The floating
mucus and foam were removed by aspiration, yielding -1.5 ml of a
transparent solution. The protein concentration of the venom stock was
adjusted to -4 mg/ml and was kept frozen at -20°C for several weeks
without a significant loss of activity. RyTx was purified in a gradient
high-performance liquid chromatography (HPLC) system (System Gold;
Beckman Instruments, San Ramon, CA) in three chromatographic steps.
Venom peptides were eluted with acetonitrile gradients (described by the
dotted lines in Fig. 1) prepared in 0.1% trifluoroacetic acid. Absorption
peaks corresponding to the peptide elution pattern were monitored at 254
nm. Fractionated absorption peaks were dried under vacuum centrifugation
at room temperature and resuspended in a minimal volume of glass-
distilled deionized water. The activity of HPLC fractions was determined
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FIGURE 1 HPLC purification of ryanotoxin. (A) Chromatographic pro-
file resulting from the injection of -500 ,g of water-soluble Buthotus
judaicus venom into a preparative C,8 reverse-phase column. Peptide
fractions were eluted with an 8.75-65% acetonitrile gradient (dashed line)
containing 0.1% trifluoroacetic acid run at a flow rate of 1.0 ml/min. (B)
Chromatographic profile resulting from the injection of 100 ,ug fraction
4 from A into an analytical C18 reverse-phase column. Fractions were
eluted with an 8.75-45% acetonitrile gradient (dashed line) containing
0.1% trifluoroacetic acid run at a flow rate of 1.0 ml/min. (C) Chromato-
graphic profile resulting from the reinjection of fraction 5 from B into the
same analytical C18 reverse-phase column. Ryanotoxin was eluted with an
8.75-30% acetonitrile gradient containing 0.1% trifluoroacetic acid run at
a flow rate of 1.0 ml/min.
by [3H]ryanodine binding, taking care that approximately the same A254
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units were assayed from each peak. Control binding in the absence of toxin
was measured side by side in each assay.
The HPLC fractionation procedure during a single preparation of RyTx
was as follows. Aliquots of -200 ,ul of venom stock were injected into a
preparative HPLC column (0.78 cm x 30 cm; mBondapac-Waters, Mil-
ford, MA). Peak 4 (Fig. 1 A) from six separate runs was pooled, dried, and
resuspended in 300-500 ,ul of water. Aliquots of --100 ,l1 of resuspended
peak 4 were injected into a analytical C,8 HPLC column (0.46 x 25 cm;
Vydac, Hesperia, CA). Peak 5 (Fig. 1 B) from three to five runs was
pooled, dried, and resuspended in 200 ,l1 of water. Aliquots of 50-100 ,l1
of resuspended peak 5 were reinjected into a similar C,8 HPLC column
above and eluted with a shalower acetonitrile gradient described in Fig. 1
C. The ryanotoxin peak from two to four runs was pooled, dried, and
resuspended in 200-300 ,l of water at a concentration of 300-600 ,g
RyTx/ml. A stimulatory unit (1 S.U.) was defined as 1 pmol of specific
[3H]ryanodine binding stimulated by toxin after subtraction of the control
[3H]ryanodine binding without toxin. A typical venom stock measures
1500 S.U.; the activity was 250 S.U./mg stock venom. From this stock, a
total of 900 S.U. was recovered in the purified RyTx fraction, and the
activity was 15,000 S.U./mg RyTx.
[3H]Ryanodine binding
Peptide fractions and controls without venom were assayed side by side in
duplicate for 90 min at 37°C in 0.1 ml binding solution composed of 7 nM
[3H]ryanodine, 0.4 mg/ml SR, 0.2 M KCl, 1 mM Na2EGTA, 0.995 mM
CaCl2, and 10 mM Na-PIPES, pH 7.2. The calculated free Ca21 concen-
tration of the binding buffer was 10 AM and was estimated as described
elsewhere (Fabiato, 1988). Samples were filtered on Whatman GF/C glass
fiber filters (Brandel, Gaithersburg, MD) and washed twice with 5 ml of
distilled water using a Brandel cell harvester (Brandel, Gaithersburg, MD).
Nonspecific binding was measured in the presence of 1 ,uM unlabeled
ryanodine. In equilibrium binding experiments, incubations of SR and
[3H]ryanodine were extended to 17-19 h at room temperature in the same
binding solution above plus 100 ,g/ml bovine serum albumin (BSA), 100
,uM phenylmethylsulfonyl fluoride, 200 ,uM benzamide, 1 ,ug/ml leupep-
tin, and 1 jig/ml pepstatin A. Nonspecific binding was determined in the
presence of 100 AM unlabeled ryanodine.
Single-channel recordings
Planar lipid bilayers were formed by using a decane solution composed of
10 mg/ml brain phosphatidylethanolamine and 10 mg/ml brain phosphati-
dylserine (Avanti Polar Lipids, Alabaster, AL). The lipid solution was
spread over a 300-,um-diameter aperture separating two aqueous chambers.
SR was added to the cis solution composed of 240mM CsCH3SO3, 10mM
CsCl, and 10 mM HEPES-Tris, pH 7.2. The trans solution was composed
of 40mM CsCH3SO3, 10mM CsCl, and 10mM HEPES-Tris, pH 7.2. The
volume of the chamber to which the cis solution and toxin were added was
-300 ,l, and that of the trans solution was 3 ml. Channel incorporation
was assisted by breakage and reformation of the bilayer in the presence of
SR and the CsCH3SO3 cis-to-trans gradient (Coronado et al., 1994). This
procedure resulted in a partial dissipation of the original Cs' gradient
established across the bilayer. Hence, the single-channel reversal potentials
were less negative than the Cs' equilibrium potential of -38 mV. The cis
and trans Cs' concentrations estimated by measuring the conductivity of
samples of cis and trans solutions at the end of a typical experiment were
in the following ranges: cis, 160-180 mM, and trans, 60-65 mM. The free
Ca21 of the cis solution was -4 ,M, as determined with a Ca2+-sensitive
electrode. The cis chamber was connected via an Ag/AgCl electrode to the
headstage input of a List L/M EPC 7 amplifier (Medical Systems, Green-
vale, NY). The trans solution was held at ground using the same electrode
arrangement. Recordings were filtered at 1 kHz with a low-pass Bessel
filter and stored on VCR tape. Recordings were digitized at 5 kHz for
analysis. Single-channel events were identified using Transit 1.0 software
(Baylor College of Medicine, Houston, TX), which uses a slope threshold
to detect the opening and the closing event and a relative amplitude
threshold to eliminate spurious transitions derived from baseline noise.
Brief events identified by a single digitized sample of current flanked by
two samples of baseline current were excluded from the amplitude histo-
grams and lifetime distributions.
Primary cultures of mouse myotubes
Primary cultures of mammalian skeletal muscle cells were prepared
from the hind limbs of 18-day mouse fetuses according to a procedure
described elsewhere (Takekura et al., 1994), with some modifications.
Mechanically dissociated muscles were incubated for 9 min at 37°C in
Ca2+'Mg2'-free Hanks' balanced salt solution (136.9 mM NaCl, 3 mM
KCl, 0.44 mM KH2PO4, 0.34 mM NaHPO4, 4.2 mM NaHCO3, 5.5 mM
glucose, pH 7.2) containing 0.25% (w/v) trypsin and 0.05% pancreatin.
After gentle aspiration and centrifugation, mononucleated cells were
resuspended in plating medium containing 78% Dulbecco's modified
Eagle's medium with low glucose (Gibco BRL, Gaithersburg, MD),
10% horse serum (Sigma, St. Louis, MO), 10% fetal bovine serum
(Sigma), and 2% chicken embryo extract (Gibco BRL) and plated on
glass coverslips at a density of 1 X 104 cells/dish. Culture were grown
at 37°C, in 98% H20 and 10% CO2. After the fusion of myoblasts
(6 days), the medium was replaced with contraction medium (88.75%
Dulbecco's modified Eagle's medium, 10% horse serum, 1.25%
chicken embryo extract), and cells were incubated in lower CO2 (5%)
atmosphere. All media contained 0.5% w/v penicillin and streptomycin.
Single-cell recordings and measurements of
intracellular Ca2+
Whole-cell recordings were made in a Axopatch ID patch clamp with a
50-Mfl feedback resistor (Axon Instruments, Foster City, CA). The re-
cording chamber was mounted on the stage of an inverted microscope for
simultaneous measurement of cell fluorescence. Standard patch-clamp
electrodes (2-5 mfl) were used to establish the whole-cell configuration
and to dialyze RyTx into the cell. External RyTx was added to the bath
solution in Krebs superfusion medium. Action potentials and intracellular
Ca21 transients were recorded at room temperature under current-clamp in
8-10-day-old cultures of mouse skeletal myotubes superfused with a
standard Krebs solution consisting of (in mM) 136 NaCl, 5 KCl, 2 CaCl2,
1 MgCl2, 10 HEPES (pH 7.4). The pipette solution was (in mM) 140 KCl,
5 MgCl2, 10 HEPES/Tris. Cells were held at -80 mV and depolarized by
16-ms current pulses of 1 to 5 nA given at 2-s intervals. The data were
filtered at 3 kHz and digitized at 50 ,us per point. Acquisition was
performed with a TLl DMA interface controlled by pCLAMP 6.0 software
(Axon Instruments). Ca2+ transients were additionally recorded under
voltage clamp in cells superfused with a standard Ca21 current recording
solution consisting of (in mM) 130 tetraethylamonium methanesulfonate,
10 CaCl2, 1 MgCl2, and 10 HEPES (pH 7.4). The pipette solution consisted
of (in mM) 140 Cs-aspartate, 5 MgCl2, 0.1 EGTA, and 10 3-(N-morpho-
lino)propanesulfonic acid (pH 7.2). Ca2+ transients in cells held under
voltage clamp were elicited by a voltage pulse of variable amplitude and a
fixed duration of 50 ms delivered every 40 s. The holding potential was
-80 mV. Intracellular Ca2+ was measured by microfluorimetry of fura-2,
using a dual alternating excitation wavelength illuminator attached to an
inverted micropscope (Photon Technology International, London, ON,
Canada). After a whole-cell recording configuration was established, a slit
of 40 X 70 mm was adjusted toward the center of the cell and away from
the patch pipette. Fluorescence emission passing through the slit area was
guided to a photomultiplier tube. Fluorescence emission was separated
from excitation by using a dicroic cube with a 400-nm dicroic mirror and
a 510/20 emission barrier filter. Emission ratios in response to alternate
340/380 nm excitation were taken at a rate of 200 ratios/s. In current-clamp
and voltage-clamp experiments, cells were loaded with 0.1 mM fura-2 AM
(Molecular Probes, Eugene, OR) for 20 min at room temperature. The
amplitudes of Ca2+ transients are expressed, as as suggested elsewhere
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(Grouselle et al., 1991), as normalized fluorescence ratios. Each 340/380
fluorescence ratio aquired during the voltage or current pulse, Rt, was
divided by the fluorescence ratio of the cell at rest before the stimulus, Rto.
Controls performed in a quartz cuvette indicated that 5 ALM RyTx did not
change the fura-2 fluorescence emission at 340 or 380 nm excitation.
Sarcoplasmic reticulum Ca2' release
Ca2+ release from SR vesicles was measured using the Ca21 indicator dye
fura-2 (Molecular Probes) in a 0.3-ml cuvette mounted on a spectrofluo-
rimeter. Excitation wavelengths were 340 nm and 380 nm, and the emitted
fluorescence spectra were recorded with a Hitachi F-2000 spectrofluorim-
eter (Hitachi, Danbury, CT). In each assay, an SR sample of 150 ,tg was
actively loaded with Ca2+ in a solution composed of 100 mM KCl, 5 mM
phosphocreatine, 5 ,ug/ml creatine phosphokinase, 0.5 ,uM fura-2 (free
acid), 1 or 2 mM ATP, and 20 mM HEPES-Tris (pH 7.2) at 250C. Ca2+
was present in the loading solution at contaminant levels in the range of
1-10 ,iM. The Ca2+ release transients were calibrated by a ratiometric
method previously described (Grynkiewicz et al., 1985).
Gel electrophoresis
Sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis was
performed as described elsewhere (Laemmli, 1970). Samples were incu-
bated for 10 min at 800C in 2% SDS, 2% b-mercaptoethanol, 10% glycerol,
and 10 mM Tris (pH 6.8). Samples were run on a 6-20% linear polyacryl-
amide gradient. Gels were stained with 0.05% Coomassie blue in 10%
acetic acid. Molecular weight standards were always run on two separate
lanes of the same gel: myosin, Mr 200,000; b-galactosidase, Mr 116,250;
phosphorylase b, Mr 97,400; BSA, Mr 66,200; ovalbumin, Mr 45,000;
carbonic anhydrase, Mr 31,000; soybean trypsin inhibitor, Mr 21,500;
lysozyme, Mr 14,000.
Chemicals and abbreviations
Deionized, glass-distilled water was used in all solutions. Na2ATP and
AMP-PCP ((3,By-methyleneadenosine 5'-triphosphate) were from Sigma.
Ryanodine and CHAPS were from Calbiochem (San Diego, CA). Ruthe-
nium red (Ruthenium III chloride oxide) was from Alpha Products (An-
dover, MA). Brain phosphatidylethanolamine and brain phosphatidylserine
were from Avanti Polar Lipids. Penicillin, streptomycin, trypsin, pancre-
atin, phosphocreatine, and creatine phosphokinase were from Sigma.
[3H]Ryanodine (60 Ci/nmol) was from Du Pont-New England Nuclear
(Wilmington, DE).
Protein assay
Protein concentration was determined by the Bradford method, with a
Bio-Rad kit (Richmond, CA), with bovine serum albumin as the standard.
Curve fitting
Curve fitting was done using the standard Marquardt-Levenberg algorithm
provided by Sigmaplot 2.0 (Jandel, San Rafael, CA) or DeltgaGraph 3.0
(DeltaPoint, Monterey, CA).
RESULTS
Purification of ryanotoxin
Ryanotoxin was purified by HPLC, using the stimulation of
[3H]ryanodine binding to junctional SR as the index of toxin
activity. Fig. 1 A shows the chromatographic profile of
-500 jig of stock venom fractionated on a preparative C18
reverse-phase HPLC column. Fractions indicated by arrows
were eluted using a 8.75-65% acetonitrile gradient (dashed
line), dried under vacuum centrifugation, and resuspended
in a minimal volume of water. The activity of each fraction
was determined by a [3H]ryanodine binding assay carried
out for 90 min at 37°C. Because [3H]ryanodine binds pref-
erentially to the open state of the channel (Imagawa et al.,
1987; Inui et al., 1988; Pessah et al., 1986), venom fractions
that increased [3H]ryanodine binding may have opened the
channel, whereas those that decreased binding may have
closed the channel. In this manner, we screened HPLC
fractions that could potentially affect channel activity and
determined that fraction 4 of Fig. 1 A, and to a lesser extent
fraction 5, stimulated [3H]ryanodine binding 1.2- to 2-fold,
depending on the concentration. Other fractions in the pro-
file inhibited [3H]ryanodine binding (fractions 1 and 6) or
had no effect (fractions 2 and 3). Fraction 4 (Fig. 1 A) was
purified further using an analytical C18 reverse-phase col-
umn. Fig. 1 B shows the chromatographic profile resulting
from the injection of -100 jig of fraction 4 (Fig. 1 A) into
the analytical column. Nearly all of the stimulatory activity
was recovered in a single A254 absorbance peak correspond-
ing to fraction 5 of Fig. 1 B. After reinjection of peak 5 into
an analytical C18 reverse-phase column, this fraction eluted
as a single homogeneous peak with a retention time of - 16
min in a 8.75-30% acetonitrile gradient (Fig. 1 C). The
stimulatory [3H]ryanodine binding activity purified accord-
ing to the three steps of HPLC chromatography described
above was identified as ryanotoxin or RyTx. The elution
profiles shown in Fig. 1 were consistently observed in 10
separate purifications of RyTx (see Materials and Methods).
To determine the polypeptide composition, a sample of 5
,jg of purified RyTx was run on a linear 6-20% SDS-
polyacrylamide gel under disulfide-reducing conditions.
Fig. 2 A shows that RyTx (lane 1) migrated as an apparently
single polypeptide of Mr --11.4 kDa, determined from a
semilog plot (Fig. 2 B) of the mobility of RyTx and the
indicated markers run on the same gel. On the other hand,
the water-soluble unfractionated venom (Fig. 2 A, lane 2)
consisted of high- and low-molecular-weight peptides in the
range of - 130 kDa to 6 kDa, with the majority of the
peptides concentrated at - 10 KDa. In separate gel runs (not
shown), samples of 20 ,.g RyTx migrated as a single band
with a mobility similar to that above, although the staining
pattern was more diffuse. RyTx was thus largely free of
high-molecular-weight peptides present in the venom and
was likely to consist either of a single polypeptide or several
distinct polypeptides of highly similar molecular weights
and HPLC elution profiles. Based on the total A254 absor-
bance units of the venom stock and the amount of protein
recovery in the purified sample, RyTx represented, respec-
tively, -0.5% and -2% of the total water-soluble venom.
The enrichment in [3H]ryanodine binding stimulatory activ-
ity in the purified RyTx fraction was approximately 30-fold,
and the recovery of the stimulatory activity in the RyTx
fraction was typically 60% (see Materials and Methods).
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FIGURE 2 (A) Electrophoretic analysis of ryanotoxin. Coomasie blue staining of a 6-20% SDS polyacrylamide gel. Lane 1: 2.5 ,ug RyTx. Lane 2: 5
,ug Buthotus judaicus venom stock solution. Molecular weight markers in the same gel are indicated by lines. (B) Molecular weight markers are plotted
as a semilog function of the retention in the gel, the latter defined as the distance moved by the marker from the loading trough divided by the distance
between the loading trough and the dye front. The asterix indicates the mobility of RyTx resulting in a calibrated apparent molecular mass of 11.4 kDa.
However, the calculated enrichment of activity and yield is
only approximate, because the stock venom was composed
of peptides that stimulated and inhibited [3H]ryanodine
binding, and part of the stimulatory activity of purified
RyTx probably was masked in the unfractionated venom.
Characteristics of the ryanotoxin-modified
ryanodine receptor channel
The left and center panels of Fig. 3 show recordings of a
ryanodine receptor during a control period, and after the
addition of 1 ,uM ryanotoxin to the cis solution. The main
effect of the peptide was to induce a conductance state with
a unitary value -40% lower than that seen during the
control period. Furthermore, the mean duration of the sub-
state was much longer than that of the open state seen
during controls. Thus, in the presence of the peptide, the
channel alternated between closed, open, and substate con-
figurations, with the largest fraction of time spent in the
substate. The substate always appeared within seconds of
peptide addition, and in most cases, during the period of
solution stirring, which lasted no more than 15 s. Because
ryanodine is known to induce a long-lived substate, we
compared the characteristics of both substates under the
same recording conditions. The right panel of Fig. 3 shows
recordings from a separate ryanodine receptor modified by
1 ,uM ryanodine. In agreement with reports describing the
effect of similar concentrations of the alkaloid on skeletal
ryanodine receptors (Imagawa et al., 1987; Lai et al., 1989),
ryanodine induced a substate with an extremely large prob-
ability of occurrence, which in this case was >0.95.
Fig. 4 shows amplitude histograms of all nonclosed
events at 0 mV (n > 1000 in each histogram) for a control
recording and for recordings of RyTx- and ryanodine-mod-
ifed channels. Control events were clustered into a single
peak with a mean of 11 pA, which represented the unitary
current of the open state. A trailing edge below the mean
represented both brief events attenuated by the filter cutoff
frequency of 1 kHz (-3 dB) and events of low amplitude
that are clearly present in Fig. 3 and elsewhere (Morrissette
et al., 1995). Events collected from a RyTx-modified chan-
nel were distributed into a peak of 10.4 pA corresponding
to the toxin-unmodified open state and a peak of -3.5 pA
representing the mean unitary current distribution of the
substate induced by RyTx. On the other hand, events col-
lected from a ryanodine-modified channel had a somewhat
broader distribution, with a mean of -3.9 pA representing
the mean unitary current of the substate induced by ryano-
dine. Events representing the ryanodine-unmodified open
channel were not present. The similarity in unitary current
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FIGURE 3 Effect of ryanotoxin on skeletal ryanodine receptor channels. The same channel is shown in the absence (control) and presence of 1 ,uMA
ryanotoxin. A separate channel is shown in the presence of 1 ,tM ryanodine. All recordings were made at 0 mV using Cs' as the current carrier. The
baseline is indicated by the solid line. The probability of the open state was 0.21 in control and 0.13 in the presence of RyTx. The probability of the substate
was 0.38 in the presence of RyTx and 0.90 in the presence of ryanodine.
amplitude of the substates induced by RyTx and ryanodine
was confirmed at several voltages above and below the
reversal potential (Fig. 5). Current-voltage curves in Fig. 5
A are for the open state during the preceding control period
(squares), and for the substate induced in the same channel
by RyTx (circles). A linear fit of the data showed that RyTx
induced a substate with a mean conductance of 163 pS. This
value represented a 2.37-fold reduction in conductance
(387/163) relative to the conductance of open state during
the preceding control period. On the other hand, the reversal
potential of the substate was the same as that of the control
open state and suggested that RyTx did not noticeably
change the ionic selectivity of the channel. Current-voltage
curves for a ryanodine-modified channel, and for the open
state before alkaloid addition, are shown in Fig. 5 B. The
substate induced by ryanodine had a mean conductance of
174 pS, which represented a 2.32-fold reduction in conduc-
tance (405/174) relative to its control. As in the case of
RyTx, the reversal potential of the ryanodine-modified
channel remained invariant. A Student's t-test analysis of
two populations with different sample means showed that
neither the conductance of the substates induced by RyTx or
ryanodine (163 ± 12 pS versus 173 ± 26 pS), nor the
conductance of the open state during the two control periods
(387 ± 35 pS versus 405 ± 14 pS) was significantly
different (p < 0.05). From these results we concluded that
ryanotoxin and ryanodine induced conductance states of
identical unitary value.
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FIGURE 5 Current-voltage relationships of ryanotoxin- and ryanodine-
modified openings. Current-voltage curves are shown for the control chan-
nel (squares) and for the substate (circles) induced in the same control
channel by 1 ,uM RyTx (A) or by 1 ,uM ryanodine (B). The mean and
standard error of a linear fit are shown for each curve.
Even though substate conductances were identical, the
RyTx-modified channel differed from the ryanodine-modi-
fied channel in other respects. For example, the recordings
of Fig. 3 clearly showed that the RyTx-modified channel
could undergo transitions between the substate and a large
apparently unmodified open state or between closed and
open states, whereas the ryanodine-modified channel could
not. Thus, we investigated the kinetics of the RyTx- and
ryanodine-modified channels. Open events during control
(Fig. 6 A), and large openings after exposure to ryanotoxin
(Fig. 6 B) had distributions that were clearly monoexponen-
tial, with nearly the same mean open time. This result
confirmed that some unmodified open events were indeed
present after exposure to RyTx. Distributions of substate
events induced by ryanotoxin (Fig. 6 C) as well as by
ryanodine (Fig. 6 D) were biexponential. Because the mean
duration of the substate induced by ryanotoxin was 5- to
10-fold shorter than that induced by ryanodine, the kinetic
modification induced by ryanodine appeared to be much
more stable than that induced by the peptide.
The presence of an open state in the ryanotoxin-modified
channel with the same conductance and mean duration as
that of control channels suggested that ryanotoxin could
freely associate and dissociate from the channel. Thus when
ryanotoxin was bound to the channel, the substate would be
formed, but when it dissociates from its binding site, the
channel may transiently open and close with unmodified
kinetics. Inspection of the recordings further indicated that
ryanotoxin was likely to dissociate either from the closed
state or from the open state, because transitions between the
substate and the open state and between the substate and the
close state were almost equally represented in the data (not
shown). We sought to test the hypothesis that ryanotoxin
could dissociate from the channel by determining the sen-
sitivity of ryanotoxin-modified channels to inhibition by
ruthenium red. It has been shown that ruthenium red can
irreversibly block open-closed transitions of control chan-
nels, but that the substate induced by ryanodine is insensi-
tive to ruthenium red (Imagawa et al., 1987; Nagasaki and
Fleischer, 1988; Ma, 1993). In agreement with the previous
results, Fig. 7 A shows that control openings were rapidly
inhibited by 1 ,uM ruthenium red added to the cis solution.
On the other hand, the probability of occurrence of the
substate induced by ryanodine shown in Fig. 7 B was
unchanged by ruthenium red. Fig. 7, C and D, shows an
experiment in which 1 mM ruthenium red was added to a
ryanotoxin-modified channel and activity was followed
thereafter. Open events (Fig. 7 C) and substate events (Fig.
7 D) were inhibited by ruthenium red with a significant
delay, which in this case was -40 s after the completion of
solution mixing. The fact that channel inhibition was ob-
served indicated that a ruthenium red-sensitive open state
and/or substate was indeed present in the RyTx-modified
channel. Furthermore, the fact that inhibition occurred with
a delay not seen in controls suggested that the open state,
which had a low probability of occurrence, and not the
substate, which had a high probability of occurrence, was
the target of ruthenium red. These results provided an elec-
trophysiological indication that RyTx may in fact tran-
siently dissociate from the channel, thus making the open
RyTx-free channel available to inhibition by ruthenium red.
Stimulation of SR Ca2' release by ryanotoxin
If RyTx generated a long-lived conducting state in the
ryanodine receptor, incubation of SR with the peptide
should result in a release of stored Ca2+. To determine
whether this was the case, we used the fluorescent Ca21
indicator fura-2 to monitor Ca2+ release from the SR spec-
trofluorimetrically. Ca2+ was actively loaded into the SR by
the addition of 2 mM MgATP to a cuvette containing 0.5
mM fura-2 (free acid), 0.4 mg/ml SR, contaminant-free
Ca2+ (1 to 3 ,uM), 150 mM KCl, 5 mM phosphocreatine, 5
mg/ml creatine phosphokinase as an ATP-regenerating sys-
tem, and 20 mM HEPES-Tris (pH 7.2). Experiments were
terminated with additions of 1 mM Ca2+ and 10 mM EGTA
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FIGURE 6 Time distributions of ryanotoxin- and ryanodine-modified open events. Distributions of 5702 open events during a control period (A) and 1420
open events after the addition of I ,uM RyTx (B) are from the same channel. Distributions of 1420 substate events induced by 1 ,uM RyTx (C) or 733 events
induced by 1 ,uM ryanodine (D) are from separate channels.
to calibrate the extravesicular free Ca2+ according to the
ratiometric technique (Grynkiewicz et al., 1985). As shown
in each of the four traces of Fig. 8, the addition of ATP
resulted in a large decrease in extravesicular free Ca2 ,
which was almost exclusively due to the stimulation of the
SR Ca2+ pump. The addition of ATP in the absence of SR
resulted in a small decrease in fluorescence due to ATP-
Ca2+ binding, which was on the order of -0.02 nmol of
free Ca2+. This value was small compared to the active
sequestration, which was typically in the range of 0.35 to
0.75 nmol of free Ca2 . Uptake had a rate of 4 to 10 nmol
Ca2+/mg SR/min, which agreed well with previous results
(C. Valdivia et al., 1992). Controls using 10 ,uM thapsigar-
gin demonstrated that >50% of Ca2+ accumulated in the
SR could be released within 30 s of the addition of drug. As
shown in Fig. 8 A, the addition of 10 mM caffeine after
completion of the Ca2+ loading phase resulted in a sudden
release of stored Ca2+ equivalent to -0.8 nmol Ca2+/mg
SR. The release was followed by a slower Ca2+ removal
phase lasting several minutes as the released Ca2+ was
driven back into vesicles by the Ca2+ pump. As expected
from a ryanodine receptor-mediated process, the caffeine-
induced release could be blocked by the prior addition of 1
,uM ruthenium red (Fig. 8 B). In a separate experiment, the
addition of 100 nM RyTx to the cuvette after completion of
the Ca2+ loading phase resulted in the release of -0.53
nmol Ca2+/mg SR (Fig. 8 C). The Ca2+ release induced by
the peptide was blocked by ruthenium red (Fig. 8 D), which
demonstrated that the release occurred by the activation of
ryanodine receptors. These results demonstrated that RyTx,
like caffeine, could promote a significant release of SR
stored Ca2+, presumably by opening many ryanodine re-
ceptors simultaneously, so that the Ca2+ removal rate set by
the Ca2+ pump was overcome by the Ca2+ release rate
enhanced by the toxin.
Stimulation of Ca2+ transients by ryanotoxin in
skeletal muscle myotubes
To determine the effectiveness and specificity of RyTx in
cells, we performed recordings in primary cultures of mouse
myotubes. Fig. 9 A shows action potentials in a control
myotube bathed in Krebs solution and separately in a myo-
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FIGURE 7 Diary of event probability modified by ruthenium red. Open or substate probability was measured continuously during intervals of 683 ms
and was plotted as a bar of length 0 to 1. Recording period in the presence of cis 1 ,uM ruthenium red is indicated by arrows. Separate recordings are shown
for a control (A), ryanodine-modified (B), and ryanotoxin-modified (C, D) channels.
tube exposed to Krebs solution containing 5 ttM RyTx.
Cells were maintained under current clamp at a holding
current adequate to keep the resting potential at -80 mV.
Action potentials (labeled 1 to 5) were each elicited by a
current pulse of amplitude 1 to 5 nA with a constant incre-
ment of 1 nA from one pulse to the next. Thus, the action
potential labeled 1 was elicited by 1 nA, whereas the action
potential labeled 5 was elicited by 5 nA. Each pulse lasted
16 ms; these were given at intervals of 2 s. The initiation
and termination of the current pulse are clearly visible in
records 2 to 5 as a fast charge and discharge of the cell
capacitance mounted on the time course of the action po-
tential. As the amplitude of the stimulus increased, the delay
in triggering the action potentials became equally short in
the control and toxin-exposed myotubes. Furthermore, the
shape of the action potential and maximum depolarization
were not affected by the toxin. In addition, a comparison of
the upstroke velocity in control and toxin-exposed cells
indicated that this parameter remained unchanged (155 +
45 V/s (n = 5 control cells) and 155 + 39 V/s (n = 5
RyTx-exposed cells)). These results indicated that RyTx, at
concentrations used in planar bilayer experiments, did not
affect the fast Na+ and K+ current components of the
skeletal muscle cell action potential and did not affect the
Na+ and K+ gradients underlying the action potential. Fig.
9 B shows that when the peptide was dialyzed into cells
through the patch pipette filled with 5 zM RyTx, there was
a large potentiation of the Ca2+ transient elicited by a pulse
to +30 mV. In these recordings, the cell was ruptured, and
whole-cell voltage-clamp configuration was established 1-2
min before the recording of the Ca2+ transient. The time
between rupturing of the cell with the pipette and the
recording of the train of Ca2+ transients appeared sufficient
for the peptide to diffuse out of the pipette and to increase
(A)
0.4-
, 0.3-
cn
a)
OL 0.2-0
0
0~CL
0.1 -
0- r5----0 -250
(C)
1 -
0.8-
it
0.6-
a)
0
o 0.4-
a
0.2-
0
.....
Morrissette et al. 715
716 Biophysical Journal ~~~~~~~~~~~~Volume71 August 1996
MgATP
1 mM Ca2CI
10 mM Caffeine
10 mM EGTA
100 200
Time (sec.)
MgATP
1
(B)
2
CM
7- 1
a1)
Cu<
wU
300
(D)
ic
Cui
0
7-i
0
w
DOO0.
2 mM. MgATP
100 200
Time (sec.)
MgATP
1 mm
0 100 200 300 0 100 200
Time (sec.) Time (sec.)
10mM EGTA
300
300
FIGURE 8 Stimulation of SR Ca2' release by ryanotoxin. Ca21 was actively loaded into the SR by 2 mM MgATP in the presence of 0.5 mM fura-2
(free acid), -0.4 mg/mi SR, contaminant-free Ca21 (1-3 KLM), 150 mM KCI, 5 mM phosphocreatine, 5 mg/mi creatine phosphokinase, 20 mMM
HEPES-Tris, pH 7.2. (A) Ca2' release induced by 10 mM caffeine. (B) Block of caffeine-induced Ca2' release by piM ruthenium red. (C) Ca21 release
induced by 100 niM RyTx. (D) Block of peptide-induced Ca2' release by piM ruthenium red. CaCl2 (1mM) and Na2EGTA (10 mM) were added at the
end of each experiment to determine Fmax and Fmin.
peak Ca2 Intracellular Ca2 transients were elicited by
voltage pulses of variable amplitude from -40 to +60 mV
and a fixed duration of 50 ins. Between pulses there was a
rsigperiod of 40 s In control cells, the Ca transient
monitored by fura-2 resulted in a doubling of the fluores-
cence 340/380 ratio relative to the resting ratio, and this
increase was almost simultaneous with the onset of the
pulse. However, the resting fluorescence ratio between
pulses was unaffected by the toxin. The peak fluorescence
was followed by a decay due to Ca2+ removal, which in
control cells had a tl12of 0.3 to 0.5 s and which agreed with
previous reports (Grouselle et al., 1991; Garcia and Beam,
1994). RyTx produced a substantial delay in the onset of
Ca2+ removal, increasing the tl/25- to 10-fold. The increase
in peak Ca2 during the transient was insignificant at -10
mV, but increased by -4 fold and more at large positive
potentials (Fig. 9 C). Only dialyzed but not externally
applied toxin was capable of stimulating Ca2+ transients,
suggesting that the peptide did not readily penetrate the cell
membrane. These recordings demonstrated that RyTx selec-
tively stimulated voltage-induce Ca2+ release without af-
fecting the overall resting free Ca2+ nor the surface mem-
brane currents controlling cell excitability.
Stimulation of [3Hjryanodine binding
by ryanotoxin
To investigate the ligand-binding properties of RyTx and
the potential interaction between RyTx and ryanodine-bind-
ing sites, we took advantage of the fact that the rate of
binding of [3H]ryanodine is proportional to the number of
open channels (Imagawa et al., 1987; Inui et al., 1988;
Pessah et al., 1986). Accordingly, we measured the amount
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FIGURE 9 Stimulation of intracellular Ca21 transients by ryanotoxin. (A) Action potentials in myotubes held under whole current-clamp in Krebs
solution (control) or Krebs solution plus 5 ,uM RyTx. After whole-cell configuration was established, the holding current was adjusted such that the resting
potential was -80 mV in all cases. Action potentials 1 through 5 were elicited by square current pulses of 16 ms of amplitude 1 through 5 nA, respectively.
(B) Ca21 transients in separate cells held under whole-cell voltage-clamp. The transient was elicited by a 50-ms voltage pulse to +30 mV. In the test cell
(filled circles) RyTx was present in the pipette solution at the indicated concentration. (C) Average peak Ca2+ during Ca2+ transient elicited by the indicated
step depolarization. Mean and SD of four control cells (squares) and three RyTx-loaded cells (circles). Rto corresponds to the fluorescence ratio at rest
before each pulse and Rt to the peak ratio fluorescence.
of specifically bound [3H]ryanodine at a fixed time before
equilibrium and correlated changes in the binding activity of
[3H]ryanodine with changes in the number of channels
opened by the peptide. As shown in Fig. 10, control binding
was 1 to 2 pmol of [3H]ryanodine bound/mg SR during a
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FIGURE 10 Stimulation of [3H]ryanodine binding by ryanotoxin. Spe-
cific binding was determined in the presence of the indicated concentra-
tions of RyTx. The solid line corresponds to a fit of the data according to
a single-site isotherm containing an additional linear term for the control
binding. Specific Binding = Bmax/(l + Kd/[RyTx]) + Bmin, where Bmax =
2.9 pmol/mg, Bmin = 1.2 pmol/mg, and Kd = 0.16 ,uM.
preestablished 90-min assay at 37°C. This binding repre-
sented a small fraction of the Bmax at equilibrium, which
was - 15 pmol/mg. RyTx at concentrations between 30 nM
and 3 ,uM increased [3H]ryanodine binding in a concentra-
tion-dependent manner from 1.3 pmol/mg to -3.8
pmollmg or -3-fold. The concentration that produced half-
maximum stimulation was 200 ± 25 nM RyTx. The 3-fold
increase in [3H]ryanodine binding at saturating concentra-
tions of RyTx correlated well with the increase in channel
activity produced by RyTx in the micromolar range (see
Discussion). These data demonstrated that the substate in-
duced by RyTx represented a conformation favorable for
the binding of the alkaloid. Fig. 11 shows that the stimula-
tion of [3H]ryanodine binding by RyTx was reversible,
because removal of RyTx by extensive wash of the SR
sample before incubation with [3H]ryanodine restored the
binding activity to control levels. This observation demon-
strated that RyTx could readily dissociate from the channel
and agreed with the inhibition of the RyTx-modified chan-
nel by ruthenium red described above.
In Fig. 12 we investigated the effect of RyTx on the
binding of [3H]ryanodine under equilibrium conditions to
determine whether the peptide modified the alkaloid-bind-
ing affinity, the binding site density, or both. Because the
rate at which [3H]ryanodine binds to the receptor is ex-
tremely slow, overnight incubations of 17-19 h were re-
quired to reach equilibrium. Under these conditions, prote-
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FIGURE 11 Reversible stimulation of [3H]ryanodine binding by ryano-
toxin. In prewash, three separate SR samples were incubated for 15 min in
binding buffer without (control) or with 0.1 jiM RyTx. All samples were
incubated with 7 nM [3H]ryanodine, and specific binding was determined
at 90 min in duplicates of each sample. In postwash, three separate SR
samples were incubated for 15 min in binding buffer without (control) or
with 0.1 AM RyTx. Samples were pelleted and resuspended in binding
buffer without peptide and incubated with 7 nM [3H]ryanodine. By Stu-
dent's t-test for the difference between two population means, each mean
from an independent sample, any two bars with a single asterisk (*) were
significantly different (p < 0.01), and any two bars with two asterisks (**)
were not significantly different.
olysis of the receptor can lead to a decrease in binding
activity (Wang et al., 1993). To minimize this problem,
protease inhibitors and 100 Ag/ml BSA were added to the
incubation solution. Fig. 11 A shows the equilibrium bind-
ing of [3H]ryanodine in the presence of 0.3 ,uM or 0.6 ,uM
RyTx, and in the presence of the known activator AMP-
PCP. The effect of the peptide was to produced a shift in the
[3H]ryanodine binding isotherm toward lower ryanodine
concentrations. Furthermore, the shift produced by 1 mM
AMP-PCP, which is known to bind to a site different from
the ryanodine-binding site (Zorzato et al., 1990; Witcher et
al., 1994; Callaway et al., 1994), was equal to that produced
by 0.3 AM RyTx. The Scatchard analysis shown in Fig. 12
B indicates that the stimulation by RyTx or AMP-PCP was
due exclusively to an increase in the affinity of [3H]ryano-
dine for the binding site without a significant change in the
Bmax. In three separate experiments, the values of Bmax (in
pmollmg) were 17 2.2 (control), 15.1 + 1.4 (AMPCP),
15.1 + 1.5 (0.3 ,uM RyTx), and 16.2 + 4.8 (0.6 ,uM RyTx).
On the other hand, the apparent dissociation constant for
[3H]ryanodine decreased from 37.7 + 4.9 nM in the control
solution to 12.5 + 1.2 nM in the presence of AMPPCP, 12.9
+ 1.3 nM in the presence of 0.3 AM RyTx, and 9.8 + 3 nM
in the presence of 0.6 ,uM RyTx. These data demonstrate
that [3H]ryanodine binds with increased affinity to the
RyTx-bound receptor. Furthermore, the fact that RyTx did
not displace but rather enhanced [3H]ryanodine binding
ruled out the possibility that the two ligands might share the
same binding site on the receptor.
DISCUSSION
We purified and characterized ryanotoxin, an -11.4-kDa
peptide from the venom of the scorpion Buthotus judaicus
that modifies the single-channel conductance and kinetics of
skeletal ryanodine receptors and potentiates intracellular
Ca2+ transients in myotubes. The fact that RyTx increased
the binding affinity of [3H]ryanodine and that 1251-labeled
RyTx (not shown) bound the solubilized ryanodine receptor
complex suggested that binding sites for the peptide may be
actually present on the surface of the receptor or in closely
associated protein. RyTx migrated with a molecular weight
larger than that of two neurotoxins purified from the same
venom, namely BJ IT-I and BJ IT-II, with molecular masses
of -7 kDa (Lester et al., 1982). In addition, RyTx did not
affect the upstroke velocity of the action potential in myo-
tubes, indicating that RyTx was unrelated to the previously
identified Na+ channel toxins. Peptides that stimulated
[3H]ryanodine binding have been described previously in
the venoms of the scorpions Pandinus imperator (H.
Valdivia et al., 1992) and Buthotus hottentota (Morrissette
et al., 1995). Imperatoxin A purified from P. imperator (H.
Valdivia et al., 1992) and ButhA-1 and ButhA-2 purified
from B. hottentota (Morrissette et al., 1995) differed from
RyTx in their apparent molecular weights and in the fact
that these peptides increased the open probability of skeletal
ryanodine receptors without modifying the single-channel
conductance. Furthermore, B. judaicus and B. hottentota
venoms had the same peptide profile as shown in Fig. 1 A;
however, ButhA- 1 and ButhA-2 migrated with a peak
equivalent to peak 5 of Fig. 1 A (Morrissette et al., 1995),
whereas RyTx was purified from peak 4 of Fig. 1 A. These
observations indicated that none of the stimulatory peptides
previously fractionated from scorpion venoms had the same
HPLC mobility or produced the same functional modifica-
tions of ryanodine receptors as seen with RyTx.
The conductance change induced by RyTx was similar to
that produced by the alkaloid ryanodine and consisted of a
long-lived substate with a conductance -2.3-fold lower
than the open state conductance. The stimulation of [3H]ry-
anodine binding by RyTx can be explained on the basis of
the increase in open and substate probabilities produced by
the peptide under the assumption that open and substate
conformations but not closed conformations favor the bind-
ing of ryanodine. A concentration of 1 AM RyTx decreased
the probability of the open state from 0.21 to 0.13 and, at the
same time, increased the probability of the substate from
null to 0.38 (Fig. 3). Thus the probability of the conducting
states induced by RyTx, assumed to represent a favorable
conformation for the binding of ryanodine, increased from
0.21 to 0.51, or 2.4-fold. The latter increase in probability
was similar to the -3-fold stimulation of [3H]ryanodine
binding produced by 1 FiM RyTx (Fig. 10).
Ligand binding analysis indicated that the pharmacolog-
ical effects of RyTx and ryanodine did not originate from
binding of these ligands to the same site(s) on the receptor.
This was demonstrated by the fact that RyTx did not change
718 Biophysical Journal
RyTx-Induced Opening of Ryanodine Receptors
FIGURE 12 Analysis of ryanotoxin
stimulation of [3H]ryanodine binding.
(A) Equilibrium binding was performed
in the absence (E) or presence of 1 mM
AMP-PCP (-), 0.3 ,uM RyTx (A), or
0.6 ,uM RyTx (-). Solid lines represent
a fit using a single binding site isotherm
to averages of three experiments. Fitted
parameters were Bmax = 17 ± 2.2
pmol/mg and Kd = 37.7 ± 4.9 nM
(control); 15.1 + 1.4 pmol/mg and 12.5
+ 1.2 nM (AMP-PCP); 15.1 ± 1.5
pmolVmg and 12.9 + 1.3 nM (0.3 ,tM
RyTx); 16.2 ± 4.8 pmol/mg and 9.8 +
3 nM (0.6 ,tM RyTx). (B) Representa-
tion of the same data and fit in Scat-
chard format.
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the Bmax of high-affinity [3H]ryanodine binding at equilib-
rium. It is also unlikely that RyTx competed for binding to
the low-affinity ryanodine-binding site(s) described else-
where (Lai et al., 1989; Pessah and Zimanyi, 1991; Wang et
al., 1993), because micromolar concentrations of unlabeled
RyTx stimulated rather than inhibited high-affinity [3H]ry-
anodine binding. Thus micromolar concentrations of RyTx
kept the ryanodine receptor open, whereas ryanodine bind-
ing to the low-affinity ryanodine-binding site(s) closes the
channel (see references above). However, because the high-
est toxin concentration tested (10 gM) may not be sufficient
to occupy all of the low-affinity ryanodine-binding sites, we
cannot exclude the possibility that RyTx may bind to low-
affinity ryanodine-binding sites with dissociation constants
of >10 ,uM. Higher concentrations of RyTx may be re-
quired to determine whether the peptide modifies the chan-
nel in a manner similar to that produced by ryanodine
binding to low-affinity sites.
There are several kinetic features established by radioli-
gand binding analysis, single-channel recording, and Ca2+
fluxes that quantitatively distinguished the actions of RyTx
from those of ryanodine. The fact that channels in the
presence of RyTx alternated between open, closed, and
peptide-modified states strongly suggested that RyTx could
freely associate and dissociate from the channel. This is in
contrast to the known effect of ryanodine, which, by binding
irreversibly, locks the channel permanently in the substate.
The reversible binding of RyTx was directly demonstrated
by SR washout experiments and could readily explain the
delayed inhibition of RyTx-modified channels by ruthenium
red. Studies using ryanodine have demonstrated that the
alkaloid induces a substate insensitive to ruthenium red
(Imagawa et al., 1987; Nagasaki and Fleischer, 1988; Ma,
1993). Assuming the RyTx-induced substate is also insen-
sitive to the blocker, the channel must leave the substate and
enter the open state to become blocked by ruthenium red.
Because the probability of the substate was higher than that
of the open state, the block by ruthenium red may have been
delayed until a sufficiently long burst of openings occurred.
Inspection of the diary of openings (Fig. 7 C) indicated that,
in fact, two bursts of openings took place immediately
before the block of the RyTx-modified channel by ruthe-
nium red. In addition, the pharmacological onset was much
faster for RyTx than for ryanodine. In single-channel re-
cordings, the time of onset of the substate was almost
instantaneous for RyTx, but required no less than 2 min, and
up to 15 min in the case of ryanodine. In fura-2 experiments
in vesicles, RyTx caused an immediate release of SR Ca2 ,
whereas 100 nM ryanodine had no effect after 5 min of
incubation (not shown). These findings suggest that the
association kinetics of RyTx with the channel may be much
faster than the association kinetics of ryanodine. A simple
explanation for the faster kinetics of RyTx binding would be
that more conformations of the ryanodine receptor (open,
closed, or spontaneous substates) permit peptide binding
than ryanodine binding.
Ca2+ transients in myotubes dialyzed with 5 ,uM RyTx
were potentiated such that the peak free Ca2+ was larger
than that of controls and the removal phase was slower than
that of controls. The slowing of removal was apparent from
a comparison of scaled traces (not shown) and from the fact
that Ca2+ remained near the maximum level for several
hundreds of milliseconds after stimulation. In contrast, re-
moval was immediately obvious in control cells after stim-
ulation. The slowing of removal was consistent with the
observation in planar bilayers that RyTx prolonged the
opening of the ryanodine receptor channel and, in so doing,
tipped the net Ca2+ transport balance in the direction of
release. Interestingly, the resting fluorescence of cells dy-
alized with RyTx was not modified. This result suggests that
the average concentration of RyTx in cells may have not
reached the micromolar range, and therefore closed chan-
nels were not opened by the toxin, as shown in planar
bilayer and SR Ca2+ flux experiments. On the other hand, it
is entirely possible that RyTx dialyzed into cells was able to
bind channels and thus prolong Ca2+ release, once these
channels were open, by the voltage sensor or by cytoplasmic
Ca2+ released from the SR. Because in the skeletal muscle
cell, the activation and well as the inactivation of Ca2+
release are under the control of the voltage sensor (Rios et
Morrissette et al. 719
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al., 1991), RyTx bound to ryanodine receptors may have
altered either or both processes.
A potentiation of the Ca2+ transient could have also
resulted from a possible stimulation of Ca2+ entry into the
cell by the toxin. However, this was unlikely because as
indicated above, the resting fluorescence of cells dialyzed
with RyTx was not affected. In addition, in whole-cell
recordings of myotubes under voltage clamp, RyTx did not
produced a noticeable effect on L-type or T-type Ca2+
currents (not shown). Furthermore, the voltage dependence
of the Ca2+ transient in control and dialyzed cells was
indicative of a purely voltage-dependent and not a Ca2+
entry mechanism. Studies of dysgenic skeletal myotubes
expressing cardiac L-type Ca2+ channels have shown that
Ca2+ transients in these cells are a graded function of the
L-type Ca2+ current (Garcia et al., 1994). This is demon-
strated by the fact that step potentials above +20 mV
curtailed the Ca2+ transient as the driving force for Ca2+
entry into the cell was reduced (Garcia et al., 1994). In the
present study, Ca2+ transients did not diminish at positive
potentials either in control or toxin dialyzed cells, and
therefore a Ca2+ entry mechanism could not possibly ex-
plain the potentiation of the Ca2+ transient.
Small venom-derived peptides such as imperatoxin A (H.
Valdivia et al., 1992) or peptide A derived from the amino-
terminal portion of the II-III loop of the a, subunit of the
DHP receptor (Lu et al., 1994; El-Hayek et al., 1995) have
been shown to stimulate opening of the ryanodine receptor
channel at relatively low concentrations. Both types of
peptides demonstrate a tissue specificity that leads to the
activation of skeletal but not cardiac ryanodine receptors.
This may be indicative of a common binding domain on the
skeletal isoform. Because the increase in activity produced
by imperatoxin A or the II-III loop peptide was not associ-
ated with changes in single-channel conductance, the phar-
macological action of RyTx may be indicative of a separate
binding domain for the latter peptide. Ligand binding com-
petition between different venom-derived peptides and the
II-Ill loop peptide may be used to establish the functional
relations between these putative binding sites. Although the
functional significance of these peptide-binding domains is
currently unknown, these studies may ultimately serve to
identify domains of the ryanodine receptor stimulated dur-
ing skeletal-type excitation-contraction coupling.
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